The Society for RNA Therapeutics

MCI USA Helps Launch Professional Society in Cutting-edge Science and Research


Washington, DC, USA, May 4, 2023. MCI USA’s Association Solutions division is pleased to welcome the Society for RNA Therapeutics as a new full-service association management client. The mission of the newly formed nonprofit scientific society is to promote research, education, and developments in RNA therapeutics to improve global health. RNA therapeutics have the potential to revolutionize numerous potential medical applications, including treatment of genetic diseases, cancer treatment, vaccines, regenerative medicine, and rare diseases.  

“MCI USA immediately saw the value and importance of helping to create a new organization to serve and support this incredibly dynamic area of science, medicine, and research. Opportunities to launch new organizations in high growth fields are directly aligned with our overall USA and global strategy, and we are honored to work with brilliant leaders creating the future of medicine,” said Erin Fuller, Chief Strategy Officer, MCI USA. “The MCI team is proud of our partnership with the inaugural board of directors to launch the Society for RNA Therapeutics, during this exciting time of establishing a new, global organization that will help treat genetic diseases and cancer as well as develop vaccines.”  

The Society for RNA Therapeutics is a global network with goals that impact all aspects of RNA therapeutics: 

  • Support translational research and development of RNA therapeutics 
  • Develop standards for RNA manufacturing and guidelines for clinical trials 
  • Facilitate public-private-regulatory partnerships and to advocate for accessible RNA therapeutics for all patients 
  • Provide public and professional education and develop training guidelines 
  • Advocate for patients with diseases amenable to RNA therapies 
  • Develop clinical best practices in RNA therapeutics 
  • Support early career and professional development 
  • Advocate accessibility to RNA therapeutics for low and middle income countries for the enhancement of global health 

“RNA therapeutics are changing the way medicine is developed and delivered,” said John P. Cooke, M.D., Ph.D., Founder and President of the Society for RNA Therapeutics. “The Society for RNA Therapeutics is led by an international group of scientists and physicians and is dedicated to serving scientists, clinicians, patient groups, policymakers and the broader public. Together, the Society will promote research, education and share key advances in this rapidly emerging field of medicine.” 

For nearly 30 years, MCI USA’s Association Solutions division has helped advance the goals of its mission-driven nonprofit clients. With more than 150 Association Solutions employees in its Chicago and Washington, DC, offices, MCI USA provides results-oriented experience and expertise in full-service nonprofit management, strategic planning, community building, creative services, accounting practices, technology solutions, event conceptualization, and more.  

Read more about the Society for RNA Therapeutics on the newly released website,


# # # 


For more information please contact: 
Andy Schwarz  
Vice President, Communications 
+1 703.506.3260  



MCI is a global engagement and marketing agency. We design human-centric solutions that unleash the power of people to deliver innovation and growth for our clients. Our offering includes live & virtual events, strategic & digital communications, consulting & community solutions. We help brands, companies, associations and not-for-profits solve their challenges, bringing their people together to shape their tomorrow. MCI is an independently owned company headquartered in Geneva, Switzerland, with a global presence in 60 offices across 31 countries.  


MCI’s US headquarters is in the Washington, DC area with offices in New York, Baltimore, Dallas, and Chicago.